Schedule 13G ownership disclosure
AnaptysBio Inc
Common Stock, par value $0.001 per share · CUSIP: 032724106
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Fairmount Funds Management LLC
Shares: 0.00 · Class: 0.0%
- Fairmount Healthcare Fund II L.P.
Shares: 0.00 · Class: 0.0%
- Peter Harwin
Shares: 0.00 · Class: 0.0%
- Tomas Kiselak
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-014001
- Form type
- SCHEDULE 13G/A
- Filer
- ANAPTYSBIO, INC
- CIK
- CIK 1370053
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership